CA: A Cancer Journal for Clinicians | 2019
Study aims to improve colorectal cancer screening rates
Abstract
Indeed, although a wide range of initiatives have been created to increase patient knowledge of available procedures and, in the case of the fecal immunochemical test (FIT), the ease of use, the percentage of adults in the United States who are up to date with CRC screening hovers in the range of the low to mid-60s, says Rachel B. Issaka, MD, MAS, an assistant member of the clinical research division and the Hutchinson Institute for Cancer Outcomes Research at the Fred Hutchinson Cancer Research Center in Seattle, Washington. According to Dr. Issaka, part of the reason is that it is not yet clear how to optimize existing evidence-based strategies to constantly engage patients in colorectal cancer screening. “The challenge has been, how do we determine and combine interventions that work best for each health care setting or patient population?” she says. “That has been really hard to tease out.”